Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Visionary Alzheimer’s forecasting software gets FDA approval
By
Aaron Dorman
Jan 30, 2024
A newly regulated Alzheimer’s software tool offers clarity on whether the condition is likely to progress to dementia in someone with mild cognitive impairment.
Ultrasound tech could allow for ultrafast Alzheimer’s treatment, study finds
By
Aaron Dorman
Jan 09, 2024
Researchers have found a way to deliver Alzheimer’s drugs faster via focused ultrasound technology, a new study shows.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
Novel method for brain stimulation could help seniors with dementia bypass brain surgery
By
Aaron Dorman
Oct 23, 2023
Researchers are testing a new method for treating people with Alzheimer’s and other dementias that would assist the brain without surgery.
CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
AI ‘can’t fly solo,’ needs humanizing context for use in healthcare, data expert emphasizes
By
Aaron Dorman
Oct 10, 2023
A researcher who builds passive AI-enabled monitoring devices believes that if more people adopted tech, it could provide invaluable data.
AI could make implantable drug delivery a realistic option for many seniors, research suggests
By
Aaron Dorman
Sep 08, 2023
Researchers have proposed an implantable drug delivery system that uses AI to help avoid buildup of scar tissue or autoimmune responses.